High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer.
Fiche publication
Date publication
avril 2020
Journal
Cellular oncology (Dordrecht)
Auteurs
Membres identifiés du Cancéropôle Est :
Mme HENRIQUES Julie
Tous les auteurs :
Zaanan A, Calmel C, Henriques J, Svrcek M, Blons H, Desbois-Mouthon C, Merabtene F, Goumard C, Parc Y, Gayet B, Taieb J, Validire P, Louvet C, Fléjou JF, Le Bouc Y, Praz F
Lien Pubmed
Résumé
The aim of this study was to investigate the association between expression of insulin-like growth factor-1 receptor (IGF1R) and its ligand, IGF-II, and disease-free survival (DFS) in patients with stage III colon cancer (CC).
Mots clés
Colon cancer, Disease-free survival, IGF-II/IGF2, IGF1R, KRAS/BRAF, MSI
Référence
Cell Oncol (Dordr). 2020 04;43(2):237-247